Step 1 topics → Hematology and Oncology → Pyruvate Kinase Deficiency

Pyruvate Kinase Deficiency

USMLE Step 1 trap: Confuses PK deficiency hemolysis mechanism with oxidative damage rather than ATP depletion. Pyruvate kinase deficiency causes hemolysis through ATP depletion, as RBCs rely entirely on glycolysis for energy and cannot maintain membrane integrity without ATP.

Pyruvate kinase (PK) deficiency is the most common hereditary enzyme defect in the glycolytic pathway and causes a chronic hemolytic anemia. USMLE Step 1 tests this mostly as a compare-and-contrast with G6PD deficiency, and the critical misconception to avoid is conflating the two: G6PD destroys RBCs via oxidative damage triggered by specific stressors, while PK deficiency causes ATP failure and produces chronic baseline hemolysis with no triggering events. RBCs have no mitochondria, so they depend entirely on glycolysis for ATP — block pyruvate kinase and the cell starves of energy, loses membrane integrity, and gets destroyed.

The exam probes two angles almost exclusively: the ATP-depletion mechanism of hemolysis, and the 2,3-BPG buildup that happens upstream of the block. When pyruvate kinase is deficient, glycolytic intermediates accumulate proximal to the defect — including 2,3-BPG. Most students see '2,3-BPG elevated' and immediately think 'bad,' but on Step 1 you need to recognize it as a partial compensatory mechanism. Elevated 2,3-BPG shifts the oxyhemoglobin dissociation curve rightward, which means hemoglobin releases oxygen more readily to tissues.

The biggest trap here is conflating PK deficiency with G6PD deficiency. Both cause hemolytic anemia in RBCs, but G6PD causes oxidative damage (Heinz bodies, bite cells, triggered by oxidative stressors), while PK deficiency causes ATP failure (no oxidative component, no triggering events, chronic baseline hemolysis). If a question gives you a patient with chronic hemolytic anemia, no oxidative trigger, and elevated 2,3-BPG, that's your PK deficiency signal. This is a low-yield topic on USMLE Step 1, but when it shows up, it almost always hinge on one of these two distinctions.

From real student decks
32%have cards covering this topic
11%have mature cards

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: Pyruvate kinase deficiency causes hemolysis through oxidative damage like G6PD deficiency.
Right: Pyruvate kinase deficiency causes hemolysis through ATP depletion, as RBCs rely entirely on glycolysis for energy and cannot maintain membrane integrity without ATP.
PK deficiency and G6PD deficiency both destroy RBCs, but through completely different mechanisms. G6PD deficiency impairs the pentose phosphate pathway, leaving RBCs unable to regenerate NADPH and neutralize oxidative stress — the damage is oxidative. PK deficiency has nothing to do with oxidative stress; it blocks the final ATP-generating step of glycolysis. Without ATP, the RBC cannot run its Na+/K+-ATPase or maintain membrane shape, so it fragments and is cleared. If you see an oxidative trigger (infection, fava beans, drugs), think G6PD; if you see chronic hemolysis with elevated 2,3-BPG and no trigger, think PK deficiency.
Common mistake
Wrong: The 2,3-BPG accumulation in PK deficiency worsens tissue hypoxia.
Right: 2,3-BPG accumulation in PK deficiency shifts the oxygen-hemoglobin dissociation curve rightward, enhancing oxygen delivery to tissues and partially compensating for the anemia.
It's intuitive but wrong to assume that any abnormal lab finding in a disease is making things worse. In PK deficiency, 2,3-BPG builds up because the metabolic block is downstream — intermediates pile up proximal to the defect. That elevated 2,3-BPG binds hemoglobin and stabilizes the deoxy (T) state, which reduces hemoglobin's affinity for oxygen and makes it unload O2 more readily at tissues. This rightward shift of the dissociation curve is the body partially compensating for having fewer functional RBCs. So elevated 2,3-BPG in PK deficiency is a silver lining, not an additional harm.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Understand why PK deficiency causes hemolysis through ATP depletion — RBCs lack mitochondria and depend entirely on glycolysis, so a block at pyruvate kinase starves the cell of energy needed to maintain membrane pumps and structural integrity.
  2. Recognize that 2,3-BPG accumulates upstream of the pyruvate kinase block and that this elevation is compensatory — it shifts the oxygen-hemoglobin dissociation curve rightward, improving oxygen unloading to tissues and partially offsetting the anemia.

Can you avoid these mistakes?

A patient has chronic hemolytic anemia since childhood with no identified triggers. Labs show elevated 2,3-BPG. Why does this patient's hemoglobin release oxygen more easily than normal, and what enzyme defect explains the elevated 2,3-BPG?
Compare the mechanism of hemolysis in PK deficiency versus G6PD deficiency. What cellular process fails in each, and how would their clinical presentations differ (triggers, chronicity, lab findings)?
A medical student says, 'The high 2,3-BPG in this PK-deficient patient must be making their tissue hypoxia worse.' How would you correct this reasoning, and what does the rightward shift of the O2-hemoglobin dissociation curve actually mean for tissue oxygen delivery?
Why are RBCs uniquely vulnerable to pyruvate kinase deficiency compared to most other cell types in the body?

Related topics

Hemolytic Anemia — Intravascular vs Extravascular Hematopoiesis and Lineage Differentiation RBC Physiology and Lifespan WBC Differential and Function Platelet Physiology and Primary Hemostasis

See how your Anki deck covers this topic.

Upload your deck for a free audit →